Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Alkermes Plc (NQ: ALKS )

19.02 USD -0.03 (-0.16%)
Official Closing Price Updated: 5:20 PM EDT, Apr 9, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Alkermes Plc

< Previous 1 2 3 4 5 6 7 8 9
...
30 31 Next >
Notable Friday Option Activity: ALKS, FND, NOC
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Alkermes plc (ALKS), where a total of 7,910 contracts have traded so far, representing... 
Tags Stocks
From Market News Video
The Daily Biotech Pulse: FibroGen Fudges Safety Data, Novartis Strikes Cancer Drug Collaboration, Immutep Gains On Patent Award
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags MTCR Benzinga Penny Stocks
From Benzinga
The Implied Analyst 12-Month Target For FNY
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
The Daily Biotech Pulse: Contrasting COVID-19 Treatment Readouts From Roche, Vir, Delay In Kadmon's FDA Review, Alzheimer's Data From Prothena
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ONTX SRDX RNLX
From Benzinga
The Daily Biotech Pulse: European Regulatory Nod For Xeris, Amicus Falls On Data, 4 IPOs, FDA Decision For Mallinckrodt's StrataGraft Delayed
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Penny Stocks Benzinga ARGX
From Benzinga
Alkermes PLC (ALKS) Q4 2020 Earnings Call Transcript
ALKS earnings call for the period ending December 31, 2020. 
Tags Market News ALKS
From Motley Fool
Why Alkermes' Q4 Results Were Better Than They Might Seem
The biotech posted a big year-over-year sales decline. But there was a good reason for it. 
Tags Market News ALKS BIIB
From Motley Fool
The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags REGN SYNH SYBX
From Benzinga
Earnings Scheduled For February 11, 2021
Companies Reporting Before The Bell • Bluerock Residential Growth REIT, Inc. Class A Common Stock (AMEX:BRG) is ... 
Tags PEP NSIT COHU
From Benzinga
Notable Tuesday Option Activity: ECOM, CCL, ALKS
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in ChannelAdvisor Corp (ECOM), where a total volume of 1,483 contracts has been traded... 
Tags Stocks
From Market News Video
The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags RCUS CLDX SMMT
From Benzinga
Answering Investors' Questions
"Rule Breaker Investing" talks to you. 
Tags SBUX AMZN Market News
From Motley Fool
The Week Ahead In Biotech (Feb. 7-13): Regeneron FDA Decision, Earnings, IPOs and Conference Presentations In The Spotlight
Biopharma stocks advanced in the week ended Feb. 5, driven higher by a slew of catalysts. Large-cap pharma earnings, vaccine updates, ... 
Tags MYOV IPOs PACB
From Benzinga
How To Trade Biotech Stocks: Can These Three Tips Help You Make More Profits?
Marc Lichtenfeld, an expert in biotech and income stocks, notes that a lot of Wall Street money moves into companies that issue positive Phase 2 clinical trial data. 
From Investor's Business Daily
The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags APM ITOS EVGN
From Benzinga
The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags LH DMTK KLDO
From Benzinga
Notable Thursday Option Activity: ENPH, CREE, ALKS
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Enphase Energy Inc. (ENPH), where a total volume of 31,652 contracts has been... 
Tags Stocks
From Market News Video
The Daily Biotech Pulse: FDA Nod For Amphastar's Generic Glucagon, Arcturus Sinks On Vaccine Data, Decision Day For Osmotica
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags IKT ALLK KOD
From Benzinga
Biotech Stocks To Watch: This Drug Firm With Key Decision Ahead Is In Buy Zone
The IBD Stock Spotlight is shining on Alkermes stock. It is currently one of the top biotech stocks to watch as it hits a new buy point. 
From Investor's Business Daily
Notable Wednesday Option Activity: BLK, ALKS, CME
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Blackrock Inc (BLK), where a total of 3,498 contracts have traded so far, representing... 
Tags Stocks
From Market News Video
First Week of August 2021 Options Trading For Alkermes (ALKS)
Investors in Alkermes plc (ALKS) saw new options become available this week, for the August 2021 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is... 
Tags Stocks
From Market News Video
The Daily Biotech Pulse: Mesoblast Releases Mixed Data, MediWound Jumps On Distribution Deal, Kezar Life Sciences Rallies On Index Inclusion, Opiant Gets BARA Funding
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ARWR NTRA NVS
From Benzinga
Stocks That Hit 52-Week Highs On Monday
Monday's morning session saw 240 companies set new 52-week highs. Key Facts: The largest company by market cap to ... 
Tags DAVA BLRX CAF
From Benzinga
Stocks That Hit 52-Week Highs On Friday
This morning 167 companies reached new 52-week highs. Noteables: Walt Disney (NYSE: DIS) was the largest firm on a ... 
Tags PNTG BCRX BIDU
From Benzinga
84 Biggest Movers From Yesterday
Gainers SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) shares climbed 176.4% to close at $17.66 on Thursday after climbing 73% on ... 
Tags THC FPAY RGLS
From Benzinga
Noteworthy Thursday Option Activity: ALKS, CVS, TDOC
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Alkermes plc (ALKS), where a total of 4,442 contracts have traded so far, representing... 
Tags Stocks
From Market News Video
Here's Why Alkermes Shares Jumped Higher Today
The biotech has a plan to increase profitability. 
Tags ALKS Market News
From Motley Fool
60 Stocks Moving In Thursday's Mid-Day Session
Gainers Immutep Limited (NASDAQ: IMMP) shares jumped 198.6% to $6.42 after the company said its Chinese partner,EOC Pharma ... 
Tags ALXO SNEX GOVX
From Benzinga
Alkermes Jumps 11% After Reaching Agreement With Activist Elliott
Shares of Alkermes are moving higher after the company announced a "Value Enhancement Plan" and cooperation agreement with activist Elliott Advisors. 
Tags Pharma/Biotech Stocks / Equities
From Blogs - TalkMarkets
3 Ways The COVID-19 Pandemic Is Actually Hurting Some Healthcare Stocks
Not everything is coming up roses for the industry. 
Tags BMY MDT SPPI
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
30 31 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.